VitalPet Intelligence

Data-Driven Updates & Releases

Access the latest clinical bulletins, software release notes, and product announcements for our smart wellness ecosystem.

Dog wearing smart activity tracker collar

Hardware & Formula Releases

Detailed specifications and rollout schedules for our newest generation of orthopedic support systems and targeted supplements.

Gen 3 Orthopedic Bed V 3.0

OrthoCore Bed Gen 3

Now integrating advanced pressure-mapping memory foam variants. Clinical trials indicate a 14% improvement in joint recovery times for senior subjects.

View Specifications
Pro Calming Supplements New Formula

NeuroCalm Pro Complex

Updated L-theanine and ashwagandha ratios based on Q3 behavioral data. Designed for optimal absorption and rapid stress mitigation during high-decibel events.

Review Data
Smart Tracker Module X Hardware

Activity Node X

Lighter casing, 45-day battery life, and enhanced accelerometer precision. The new Node X captures resting REM cycles with 98% accuracy.

Explore Module

App Release Notes

Version 4.2.0 Deployments

v4.2.1 Deployed: Oct 12

Enhanced Sleep Architecture Reporting

The companion app now breaks down resting data into Light, Deep, and REM phases, utilizing the improved algorithms from the Activity Node X accelerometer payload.

  • UI optimization for daily sleep graphs
  • Resolved sync timeout error on legacy Bluetooth protocols
v4.2.0 Deployed: Sep 28

Supplement Dosage Calculator Integration

A new module allowing precise dosage calculations based on realtime weight entries and activity burnout rates over the past 72 hours.

  • Added NeuroCalm Pro to calculation logic
  • New push notification framework for dosage reminders
Veterinary researchers analyzing joint health data

Bulletin 049

Longitudinal study results published on orthopedic interventions.

Clinical Bulletins & Efficacy Reports

At VitalPet Technologies, our products are backed by rigorous data tracking. We regularly publish our internal and partnered veterinary findings to ensure total transparency regarding product efficacy.

Q3 Mobility Index Improvements

Analysis of 12,000 active tracking nodes shows a 22% increase in sustained low-impact activity for pets utilizing the Gen 2 OrthoCore over a 90-day period.

Cortisol Reduction via NeuroCalm

Partner clinic bloodwork assays verify a measurable decrease in baseline stress markers following consistent 30-day administration of the NeuroCalm baseline formula.

Subscribe to Intel Alerts

Receive immediate notifications on firmware updates, new clinical trial results, and exclusive hardware release windows.

By subscribing, you agree to our Privacy Policy.

Direct Inquiries

Reach out to our engineering or support teams regarding hardware specifications, API access, or clinical data requests.

Transmit Message